The relationship between the patency rate of infrapopliteal lesions after endovascular treatment and wound healing rate in critical limb ischemia with tissue loss
Not Applicable
Not yet recruiting
- Conditions
- critical limb ischemia
- Registration Number
- JPRN-UMIN000016098
- Lead Sponsor
- Saiseikai Yokohama-city Eastern Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who may not complete 1 year follow-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The patency rate of infrapopliteal lesions and wound healing rate at 1, 2, 3, 6, and 12 months after endovascular treatment
- Secondary Outcome Measures
Name Time Method major amputation free rate, major amputation free survival rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence infrapopliteal lesion patency in critical limb ischemia post-endovascular treatment?
How does endovascular treatment patency rate compare to standard-of-care interventions for wound healing in critical limb ischemia with tissue loss?
Are there specific biomarkers that correlate with improved wound healing outcomes following infrapopliteal revascularization in critical limb ischemia patients?
What adverse events are associated with endovascular treatment of infrapopliteal lesions in critical limb ischemia and how are they managed?
What combination therapies or alternative approaches show promise in enhancing patency and wound healing for critical limb ischemia with tissue loss compared to the methods in JPRN-UMIN000016098?